Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description

Eichler, Klaus; Rapold, Ronald; Wieser, Simon; Reich, Oliver; Blozik, Eva

doi:10.21256/zhaw-19175

Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-19175

Full metadata record

DC Field	Value	Language
dc.contributor.author	Eichler, Klaus	-
dc.contributor.author	Rapold, Ronald	-
dc.contributor.author	Wieser, Simon	-
dc.contributor.author	Reich, Oliver	-
dc.contributor.author	Blozik, Eva	-
dc.date.accessioned	2020-01-23T15:14:44Z	-
dc.date.available	2020-01-23T15:14:44Z	-
dc.date.issued	2019-10	-
dc.identifier.uri	https://digitalcollection.zhaw.ch/handle/11475/19175	-
dc.format.extent	37	de_CH
dc.language.iso	en	de_CH
dc.publisher	ZHAW Zürcher Hochschule für Angewandte Wissenschaften	de_CH
dc.rights	http://creativecommons.org/licenses/by/4.0/	de_CH
dc.subject	Multiple myeloma	de_CH
dc.subject	Drug treatment	de_CH
dc.subject	Treatment patterns	de_CH
dc.subject	Costs	de_CH
dc.subject.ddc	362.1041: Gesundheitsökonomie	de_CH
dc.subject.ddc	615: Pharmakologie und Therapeutik	de_CH
dc.title	Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description	de_CH
dc.type	Working Paper – Gutachten – Studie	de_CH
dcterms.type	Text	de_CH
zhaw.departement	School of Management and Law	de_CH
zhaw.organisationalunit	Winterthurer Institut für Gesundheitsökonomie (WIG)	de_CH
zhaw.publisher.place	Winterthur	de_CH
dc.identifier.doi	10.21256/zhaw-19175	-
zhaw.funding.eu	No	de_CH
zhaw.originated.zhaw	Yes	de_CH
zhaw.author.additional	No	de_CH
Appears in collections:	Gesundheitsökonomie

Files in This Item:

File	Description	Size	Format
Multiple Myeloma Drug Regimes_2019.pdf		527.94 kB	Adobe PDF	View/Open

Show simple item record

Eichler, K., Rapold, R., Wieser, S., Reich, O., & Blozik, E. (2019). Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. https://doi.org/10.21256/zhaw-19175

Eichler, K. et al. (2019) Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description. Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften. Available at: https://doi.org/10.21256/zhaw-19175.

K. Eichler, R. Rapold, S. Wieser, O. Reich, and E. Blozik, “Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description,” ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Winterthur, Oct. 2019. doi: 10.21256/zhaw-19175.

EICHLER, Klaus, Ronald RAPOLD, Simon WIESER, Oliver REICH und Eva BLOZIK, 2019. Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description. Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften

Eichler, Klaus, Ronald Rapold, Simon Wieser, Oliver Reich, and Eva Blozik. 2019. “Real-World Drug Regimes for Multiple Myeloma in a Swiss Population (2012 to 2017) : Cost-Outcome Description.” Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften. https://doi.org/10.21256/zhaw-19175.

Eichler, Klaus, et al. Real-World Drug Regimes for Multiple Myeloma in a Swiss Population (2012 to 2017) : Cost-Outcome Description. ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Oct. 2019, https://doi.org/10.21256/zhaw-19175.